MedinCell S.A. (EPA:MEDCL)
France · Delayed Price · Currency is EUR 25.78
-0.16 (-0.62%)
Aug 3, 2026, 2:04 PM CET
MedinCell Income Statement
Financials in millions EUR. Fiscal year is April - March.
Millions EUR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 19.52 | 25.42 | 9.03 | 9.89 | 8.34 | |
Revenue Growth | -23.21% | 181.43% | -8.67% | 18.60% | 1.86% |
Gross Profit | 19.52 | 25.42 | 9.03 | 9.89 | 8.34 |
Selling, General & Admin | 18.48 | 14.18 | 11.81 | 9.76 | 8.54 |
Research & Development | 26.54 | 24.31 | 21.08 | 27.93 | 23.61 |
Other Operating Expenses | 0.04 | 0.08 | 0.04 | -3.75 | -4.25 |
Total Operating Expenses | 45.06 | 38.57 | 32.92 | 33.94 | 27.91 |
Operating Income | -25.54 | -13.15 | -23.89 | -24.05 | -19.57 |
Interest Income | 1.41 | 1.4 | 0.2 | 1.23 | 0.92 |
Interest Expense | -5.51 | -5.09 | -4.62 | -3.93 | -1.84 |
Other Non-Operating Income (Expense) | -6.48 | -3.75 | -0.05 | -5.26 | -0.02 |
Total Non-Operating Income (Expense) | -10.58 | -7.44 | -4.47 | -7.96 | -0.95 |
Pretax Income | -31.36 | -18.28 | -24.95 | -32.01 | -20.52 |
Provision for Income Taxes | -0.07 | 0.16 | 0.09 | - | - |
Net Income | -31.29 | -18.44 | -25.04 | -32.01 | -24.81 |
Net Income to Common | -31.29 | -18.44 | -25.04 | -32.01 | -24.81 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 33 | 30 | 28 | 25 | 25 |
Shares Outstanding (Diluted) | 33 | 30 | 28 | 25 | 25 |
Shares Change | 12.60% | 4.28% | 12.83% | 1.30% | 12.80% |
EPS (Basic) | -0.94 | -0.62 | -0.88 | -1.27 | -1.00 |
EPS (Diluted) | -0.94 | -0.62 | -0.88 | -1.27 | -1.00 |
EPS Growth | - | - | - | - | - |
Free Cash Flow | -25.37 | 18.72 | -12.25 | -21.58 | -22.99 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Per Share | -0.76 | 0.63 | -0.43 | -0.86 | -0.92 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | -130.85% | -51.73% | -264.50% | -243.16% | -234.67% |
Profit Margin | -160.30% | -72.54% | -277.21% | -323.69% | -297.50% |
FCF Margin | -129.98% | 73.64% | -135.59% | -218.23% | -275.67% |
EBITDA | -23.72 | -11.16 | -22.17 | -22.38 | -18.05 |
EBITDA Margin | -121.51% | -43.90% | -245.47% | -226.32% | -216.49% |
EBIT | -25.54 | -13.15 | -23.89 | -24.05 | -19.57 |
EBIT Margin | -130.85% | -51.73% | -264.50% | -243.16% | -234.67% |
Effective Tax Rate | 0.22% | -0.88% | -0.35% | 0.00% | 0.00% |